VIENNA - The safety of gadolinium-based contrast agents for MRI continues to generate much controversy and discussion. As both a radiologist and a lawyer, Dr. Alexander Radbruch is well-placed to comment on the most significant recent developments in gadolinium retention in the brain, how best to use these agents, and how radiologists and manufacturers can help to avoid being sued.
Video loading ...
Dr. Alexander Radbruch from Essen, Germany.
Video produced by Christof. G. Pelz I GRAFIFANT Creation. Grafik. Photo I www.grafifant.at
German study may offer new way to detect gadolinium Researchers from Germany are mulling the possibility that significantly lower T1 relaxation times may indicate the presence of gadolinium in the brains...